Results of radi- ation therapy combined with neoadjuvant hormonal therapy for stage III prostate cancer: comparison of two different definitions of PSA failure. Int J Clin Oncol 2006;11: 396-402Michihide, MitsumoriYoshihide, SasakiTakashi, MizowakiKenji, TakayamaYasushi, NagataMasahiro, Hiraoka...
However, whether the universal care translates into improved survival among patients with advanced prostate cancer in the MHS is unknown. In this study, we compared the MHS and the U.S. general population in survival of patients with advanced prostate cancer (stages III and IV). Methods The ...
To investigate any association between prostate cancer stage and ethnicity. We conducted a retrospective cohort study utilizing data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Inclusion in the study cohort required a diagnosis of prostate cancer...
Adjuvant RT May Be More Effective than Salvage for Stage III/IV Prostate Cancerdoi:10.1097/01.COT.0000295409.34692.f9NAOncology Times
Non–small cell lung cancer (NSCLC) accounts for over 80% of all lung cancers and causes more deaths than breast, prostate, and colorectal carcinomas combined. Whereas small cell lung cancer is considered a systemic, nonsurgical disease, the optimal outcome in NSCLC is predicated upon its resect...
Evaluation of prostate cancer stage groups updated in the eighth edition of the American Joint Committee on Cancer tumor-node-metastasis Staging Manual The American Joint Committee on Cancer (AJCC) tumor, node, metastasis classification system (TNM) staging manual has been updated and provides more ...
Sipuleucel-T is a type of immunotherapy that stimulates the immune system to fight cancer cells. A Phase III clinical trial known as IMPACT (Immunotherapy for Prostate AdenocarcinomaTreatment) led to the FDA approval of sipuleucel-T by demonstrating an improvement in overall survival for men treated...
However, few studies have addressed the role of cell-free plasma DNA methylation in discriminating aggressive prostate cancer (PCa) from indolent cases. We conducted a case series and a case-control study among histologically confirmed stage II/III cases and matched controls recruited at Columbia ...
Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835] Introduction Mucin 1 (MUC1) is a high molecular weight glycoprotein overexpressed on adenocarcinoma cells and is a target for immunotherapy protocols. To d... V Apostolopoulos,GA Pi...
Currently, little is known about the phenotypes of circulating tumor cells (CTCs), particularly epithelial and mesenchymal phenotypes, and their impact on the prognosis of colorectal cancer (CRC) patients. This study aims to investigate the CTC phenotypes and their prognostic implications in stage III...